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The activity oftheimmune system is regulated by a precise balance between posi-
tive and negative signals (1-2). NKcells appear to be involved in avariety ofbiolog-
ical processes, including anticancer activity, defenseagainst viral, bacterial, and fungal
infections, and resistance to parasites, among others (3-4). Although some descrip-
tions ofsuppressor cells and substances for NKantitumor activity have been reported
(5-12), the phenotype and the mechanism involved in the NK suppression process
remain unclear (9-12). Recently, we have described that the purification ofhuman
NK cells by negative selection to 398% CD16+ cells led to an increase in antibac-
terial activity that was out of proportion to the enrichment in NK cells (13). We
hypothesized thata suppressor population couldhave been removed during thecell
purification procedure. The aimofthe presentpaperis todeterminethe cellpopula-
tionthat inhibits the antibacterial activity and study the mechanism involved in the
suppression process.
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Separation of Cell Pbpulations.
￿
Suppressor and effector cells were prepared by negative se-
lection as described (13). Briefly, PBMC from healthy donors were separated on a Ficoll-
Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) cushion, followed by successive ad-
herence for60 min to aglass petriplate and passagethrough wool nyloncolumn. Monocyte-
depleted (MDC) cellswere incubatedfor 30 min at 4°Cwith the mAbs (20 Kl/106 cells) Leu-2
(anti CD8), Leu-3 (antiCD4), Leu-4(antiCD3) (BectonDickinson &Co., Mountain View,
CA) for negative selection ofNK cells, or with the mAbs Leu-3 (anti CD4) and Leull (anti
CD16) fornegative selectionofTcytotoxic/suppressor cells. The cells were placed on a poly-
styrene petri dish coated with goat anti-mouse IgG (Tago, Burlingame, CA) for 60 min at
4°C. Thenonadherentlymphoid cellswere aspirated from the plates. Thecellswere cultured
overnight in a serum antibiotic-free media HB104 (Dupont Co., Wilmington, DE) before
use. For each experiment the phenotype of nonadherent (NK or CD8 enriched) cells was
tested by direct immunofluorescence staining with FITC-conjugated Leu-1, Leu-19, Leu-2,
Leu-3, Leu-4, andLeuM1, and enumerated by either fluorescence microscopy orby FACScan
(Becton Dickinson &Co.). The surfacephenotype (%) oflymphocyte populations afterselec-
tion for NK cellswas: Leu-2 (0), Leu-3 (0.1), Leu-4 (0), Leu-11 (98.5 t 2), Leu-19 (98 t 2),
This work was supported by grants from the National Institutes of Health (CA-24773 to A. D. Bank-
burstand 1-R22 AI-24522 to F. T. Koster), andby theUNMResearch Allocation Committee (R8109).
J. Exp. MED. © The Rockefeller University Press - 0022-1007/89/08/0601106 $2.00 601602
￿
GARCIA-PENARRUBIA ET AL.
￿
BRIEF DEFINITIVE REPORT
and Leu-M1 (0); the surface phenotype (%) after selection for T cytotoxic/suppressor cells
was: Leu-2 (98 t 2), Leu3 (0), Leu-4 (97 t 2), Leu-11 (0), Leu-19 (0), and LeuMI (0).
Antibacterial Assay.
￿
Escherichia coli B/rA was obtained from T. Kagoma (UNM). The an-
tibacterial assay was performed as described (13). The percentage ofbacteria killed was deter-
mined from the expression percent killing = 100 x [(CFU experimental - CFU control)/(CFU
control)]. The data are graphed as percent killing compared to varying E/T ratios, expressed
as the loglo of NK cell number mixed with a constant number of bacteria (2.5 x 105
CFU/ml).
PGE Radioimmunoassay.
￿
Supernatants from CD8' cultured cells, from CD8' cells treated
overnight with indomethacin (1 Ag/ml; Sigma Chemical Co., St. Louis, MO), and from
CD8' cells treated with piroxicam (50 mM; Sigma Chemical Co.), were harvested. The con-
centration of PGE2 in these supernatants was determined by RIA with PGE2 1251 RIA kit
from Dupont Inc., Boston, MA.
Results and Discussion
To test the hypothesis that a suppressor population is involved in the downregula-
tion of NK cell antibacterial activity, we isolated Leu-3 (CD4') and Leu-2 (CD8')
T cells that were removed during the negative panning NK cell purification process.
Purified CD4` or CD8+ cells were co-incubated with purified autologous NK cells.
No inhibitory effect was observed when NK cells were cultured overnight in the pres-
ence of CD4+ cells (data not shown). In contrast, the antibacterial activity of NK
cells was significantly reduced after coincubation with CD8 + cells at CD8'/NK
ratios of 1 :9 and 1 :4, and this effect was dramatically enhanced at ratios larger than
1 :3 (Fig. 1 A). This appears to indicate that there is a threshold number of CD8'
cells necessary to achieve significant suppression of NK cell activity. In addition,
the threshold number of CD8' cells could also be related to the number or activity
of suppressor cells required to produce one or more suppressive factors. CD8' cell
free supernatants (CD8-SN) were harvested from 18-h cultures of purified T cyto-
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FIGURE 1.
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(A) Dependence of
CD8-induced suppressionofthe
NK antibacterial activity against
E. coli on the CD8'/NK ra-
tio. (" ) NK cells control; (O)
CD8'NK cells at 1:9 ratio; (A)
CD8'NK cells at 1 :4 ratio; (A)
'
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CD8'NK cells at 1:3 ratio;
(O) CD8'NK cells at 3:7 ratio.
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(B) Inhibition of the NK anti-
bacterial activity by exogenous
PGE2. (" ) NK cells control;
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(10-9 M); ~") NK treated with
PGE2 (10- M); (A) NK treat-
ed with PGE2 (10-7 M); (0) NK treated with PGE2 (10-6 M); (C) Effect of the arachidonic acid
metabolism inhibitors, indomethacin and piroxicam (Sigma Chemical Go.), on the CD8'-mediated sup-
pression of NK activity. The CD8' cell population was incubated overnight in the presence of indo-
methacin (1 Wg/ml) or piroxicam (50 mM) (both from Sigma Chemical Co.), washed, and coincubated
for 3 h with autologous NK cells at the CD8'/NK ratio of 3:7 in the absence and presence of exoge-
nous PGE2. (") NK cells control; (p) NK'CD8; (0) NK plus Indomethacin-treated CD8' cells; (")
NK plus piroxicam-treated CD8' cells; (A) NK plus indomethacin-treated CD8' cells plus PGE2 (10-' M);
(A) NK plus Indomethacin-treated CD8' cells plus PGE2 (10-a M). The experiments shown are repre-
sentative of five that were performed with similar results.A Ott*
z
BO
60
40
ee 20
0
GARCIA-PENARRUBIA ET AL.
￿
BRIEF DEFINITIVE REPORT
￿
603
FIGURE 2.
￿
(A) Kinetics of CD8'-mediated suppres-
sion ofNK cell antibacterial activity. Varyingnumbers
of NK and CD8' enriched populations were mixed in
medium at theCD8'/NK ratioof 3:7 and incubated at
37'C fordifferentpointtimes:(A)30 min; (A)60 min;
(/) 120 min; (0) 150 min; (p) 180 min. After each
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scribed in Fig. 1. Furthermore, theNK antibacterialac-
tivity of overnight cultured NK enriched cells, in the
absence (O) and presence (EI) of CD8' cells at the
CD8'/NK ratio of 3:7, was tested. (B) Time of onset
of (") CD8' cell-mediatedand (")CD8SN-mediated
suppression of NK antibacterial activity for a fixed
number of NK cells (5 x 104) at CD8'/NKratioof 3:7,
and30% vol/volCD8SN. Theexperiment shownis rep-
resentative of three that were performed with similar
results.
toxic/suppressor cells asdescribed (13). Effectorcells were incubatedovernight, then
washed and treated with different amounts ofCD8-SN. The results (Fig. 2 B) showed
that the CD8+ supernatants contain one or more factors that abrogate both the an-
tibacterial activity and the expression of the activation markers IL2-R and Tf-R
(datanot shown). CD8+ supernatants were suppressive at up to 1:4 dilution. Similar
results were obtained in cytotoxicity assays performed against K562 cells. Thus, at
a NK/K562 ratio of25:1, the percentage ofcytotoxicity decreased from 91 t 3%
to 16 ± 1% in the presence of CD8+ cells (CD8+/NK ratio, 3:7).
NK antitumor activity is suppressed invitro by exogenous prostaglandins (14-17).
To test whether prostaglandins were involved in the suppression ofthe NK antibac-
terial activity, theNK cell population wascultured overnight in the presence ofdifferent
concentrations of exogenous PGE2, and then tested for antibacterial activity. Fig.
1 B shows that PGE2 at concentrations of 10-7 Mcompletely abrogated the antibac-
terial activity ofpurified NK cells. This hypothesis was also tested by culturing the
CD8+ population in the presence of two different cyclooxygenase inhibitors, indo-
methacin, or piroxicam. Fig. 1 C shows that inhibition of prostaglandin synthesis
abrogated the suppressor activity of the CD8+ cells. These results suggested that
purified T cytotoxic/suppressor cells are able to produce prostaglandins that inhibit
activity ofNK cells. We also measured by specific RIA the endogenous production
ofPGE2 in overnight cultures ofpurified CD8+ cells, and CD8+ cellsplus indometh-
acin or piroxicam, without bacterial or cytokine stimulation. CD8+ cells secreted
PGE2 into the culture medium (Table I) in amounts (10-7 M) shown to inhibit NK
activity when the PGE2 is added exogenously (Fig. 1 B and references 15-17). In-604
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TABLE I
PGE2 Concentrations in 16-24 h Cultured CD8+ Cell Free Supernatants
PGE2
<7 x 10-12 M represents the limit of detection of the assay .
domethacin (1 p.g/ml) and piroxicam (50mM) blocked both the PGE2 synthesis and
suppression ofNK activity (Table I and Fig . 1 C) . Again, the addition ofPGE2 at
10-7 M restored the suppression of NK antibacterial activity (Fig. 1 C) .
We studied the kinetics of CD8+-mediated NK cell suppression by the optimal
ratio of CD8+/NK cells, or by the optimal concentration of CD8+ supernatants .
Therewas no suppression in NK antibacterial activity after a 1-hincubation (Fig . 2,
A and B) . After a2 .5-h coincubation suppression was marked, and after 3-16 h sup-
pression of NK activity was complete. The kinetics of suppression mediated by
CD8+ cell free supernatants (Fig. 2 B) was similar to that mediated by CD8 + cells .
Incubation of NK cells for 2.5 h in the presence of CD8+ supernatants prevented
and reversed the expression of the activation markers (data not shown) .
From the data shown above the following conclusions can be drawn. First, the
T cytotoxic/suppressor cell population (>,98% CD8+ cells) produce PGE2 at con-
centrations that suppress most in vitro T and NK cell functions (15-17) . Second,
the amount of PGE2 produced by resting CD8+ cells is even higher than that
reported for unstimulated monocytes and macrophages (8.5 x 10 -1° to 4.3 x 10-$
M) (18-21) . Third, PGE2 produced by CD8+ cells downregulates both antibacterial
activity and expression ofactivation markersof activatedNK cells to abaseline level
in less than 3 h. Fourth, inhibition of prostaglandin synthesis abrogates both the
suppressive activity of the CD8+ cells and their PGE2 production .
The presence of CD8 + suppressor cells explains why removal of relatively small
numbers of T cells by panning resulted in large increases in antibacterial and an-
titumorNK activity (13) . It is notable that an in vitro suppressor cell/NK cell ratio
of 1 :3 is sufficient to suppress allNK activity, in comparison to the higher physio-
logic ratio for these populations in blood of-2 : 1 . Other cells, including CD4+ cells,
may play a role in the modulation ofNK cell activity. A previous study (22) had
demonstrated PGE2 production (1 .1-1.7 x 10 -7 M) by CD8+ cells stimulated by bac-
terial antigens, but concomitant production of PGE2 by contaminating monocytes
was not excluded . The results presented here establish thatT cytotoxic/suppressor
cells bearing theCD8 phenotype are potent inhibitors ofNK cell activity and that
this mechanism is mediated by PGE2 production . The in vivo relevance of this
mechanism can now be tested using cyclooxygenase inhibitors .
Summary
We have recently described potent antibacterial activity of purified human NK
Treatment Exp . 1 Exp . 2
M
Exp . 3 Exp . 4
None 1 .87 x 10-7 1 .81 x 10-, 1 .98 x 10-7 2.32 x 10-7
Indomethacin (1 ikg/ml) <7 x 10-12 <7 x 10-12 <7 x 10-12 ND
Piroxicam (50 mM) <7 x 10-12 <7 x 10-12 <7 x 10-12 NDGARCIA-PENARRUBIA ET AL.
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cells. Here we show that this function is regulated by T cytotoxic/suppressor CD8+
cells. Thus, coculture of NK and CD8+ cells for 3 h or longer times abrogated the
expression of the NK antibacterial activity, and of two activation markers IL-2R
and transferrin receptor (Tf-R). The suppressive activity was mediated by PGE2
as demonstrated by direct PGE2 determination in CD8+ cell free supernatants, and
by inhibition of CD8+ cell suppression with indomethacin or piroxicam in vitro.
We also found that resting T cytotoxic/suppressor cells purified by negative selec-
tion produce higher amounts of PGE2 than adherent cells like monocytes and mac-
rophages, and that these concentration levels are in the range of concentrations known
to suppress a significant number of in vitro immunologic functions.
We are grateful to Michael Lennon for his technical assistance.
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